ASCO: UT MD Anderson faculty honored as 2026 Special Award recipients
Sharon Giordano will receive the Gianni Bonadonna Breast Cancer Award for significant contributions to breast cancer care and research
Eduardo Vilar-Sanchez will receive the ASCO-American Cancer Society Cancer Prevention Award for his work to advance impactful cancer prevention research
In honor of their outstanding contributions to oncology, Sharon Giordano, M.D., chair of Breast Medical Oncology, and Eduardo Vilar-Sanchez, M.D...
UT MD Anderson names Albert Koong, M.D., Ph.D., chief scientific officer
The University of Texas MD Anderson Cancer Center today announced that Albert Koong, M.D., Ph.D., an internationally recognized physician-scientist...
CPRIT awards UT MD Anderson over $19 million for cancer research and faculty recruitment
The University of Texas MD Anderson Cancer Center today was awarded over $19 million from the Cancer Prevention and Research Institute of...
Novel CAR T cell therapy developed by UT MD Anderson researchers moves into clinical studies
The novel therapy targets CD94+ relapsed or refractory T/NK cell lymphomas
UT MD Anderson received Investigational New Drug clearance from the Food and Drug Administration to begin Phase 1 clinical trial
The University of Texas MD Anderson Cancer Center and CTMC, a joint venture between UT MD Anderson and Resilience, today announced that the Food and Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational...
